Get startedLog in
    Picture of Amicus Therapeutics logo

    FOLD — Amicus Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Amicus Therapeutics Q3 Revenue USD 103.5 Million Vs. IBES Estimate USD 101.4 Million

    Picture of Amicus Therapeutics logoAmicus Therapeutics
    08/11/2023 12:00
    Nov 08 (Reuters) - Amicus Therapeutics Q3 adjusted operating expenses USD 89.8
million.
* Q3 net income USD -21.6 million
* Q3 operating expenses USD 110.6 million
* Q3 EPS USD -0.07
* outlook FY adjusted operating expenses USD 330-350 million

    Recent news on Amicus Therapeutics

    See all news